China Cord Blood Corp (CO) Formed a Bullish Wedge Up Pattern, Could Be One of The Best Performers Soon

June 20, 2017 - By Migdalia James

Investors sentiment decreased to 0.69 in Q4 2016. Its down 0.08, from 0.77 in 2016Q3. It dived, as 5 investors sold China Cord Blood Corp shares while 8 reduced holdings. 4 funds opened positions while 5 raised stakes. 6.47 million shares or 1.88% more from 6.35 million shares in 2016Q3 were reported.
Moreover, Commonwealth Of Pennsylvania Public School Empls Retrmt Systems has 0% invested in China Cord Blood Corp (NYSE:CO). Glg Prns Limited Partnership holds 0.39% or 1.61 million shares. Illinois-based Peak6 Invs Lp has invested 0.01% in China Cord Blood Corp (NYSE:CO). Wells Fargo Mn accumulated 18 shares. 28,720 were reported by State Street. Pnc Fincl Service Group has invested 0% in China Cord Blood Corp (NYSE:CO). Financial Counselors reported 0.03% stake. California Employees Retirement owns 143,700 shares or 0% of their US portfolio. Bancorp Of Montreal Can reported 1,000 shares. Moreover, Quinn Opportunity Ltd Co has 0.09% invested in China Cord Blood Corp (NYSE:CO). Advisory has 0% invested in China Cord Blood Corp (NYSE:CO). State Bank Of America De reported 40,000 shares. Parametric Port Limited Liability stated it has 19,930 shares or 0% of all its holdings. First Wilshire Secs accumulated 10,423 shares or 0.02% of the stock. Renaissance Technology holds 0.01% or 806,800 shares.

The stock of China Cord Blood Corp (CO) formed an up wedge with $9.20 target or 7.00 % above today’s $8.60 share price. The 8 months wedge indicates low risk for the $999.63M company. If the $9.20 price target is reached, the company will be worth $69.97M more.
Rising wedges, especially for downward breakouts are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 8% and 24%. The average rise is 28% and the decline is 14%. Wedges has high throwback and pullback rate: 73%, 63% and the percent of wedges meeting target is not more than 50%.

About 63,251 shares traded. China Cord Blood Corp (NYSE:CO) has risen 28.22% since June 20, 2016 and is uptrending. It has outperformed by 11.52% the S&P500.

China Cord Blood Corp (NYSE:CO) Ratings Coverage

Among 2 analysts covering China Cord Blood (NYSE:CO), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. China Cord Blood had 4 analyst reports since August 21, 2015 according to SRatingsIntel. The firm has “Sector Perform” rating given on Friday, February 5 by Howard Weil. Roth Capital maintained China Cord Blood Corp (NYSE:CO) on Friday, August 28 with “Hold” rating. TH Capital maintained China Cord Blood Corp (NYSE:CO) on Friday, August 21 with “Neutral” rating.

More notable recent China Cord Blood Corp (NYSE:CO) news were published by: which released: “China Cord Blood Corp.’s Balance Sheet is Illogical – Heng Ren” on December 14, 2016, also with their article: “China Cord Blood (CO) Q2 2017 Results – Earnings Call Transcript” published on November 18, 2016, published: “China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal …” on June 14, 2017. More interesting news about China Cord Blood Corp (NYSE:CO) were released by: and their article: “China Cord Blood Corporation Announces Termination of Evaluation and …” published on April 13, 2017 as well as‘s news article titled: “China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale …” with publication date: January 04, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.